
@ShahidNShah
VitalConnect is a leader in wearable biosensor technology for wireless patient monitoring in both hospital and remote patient populations. VitalConnect leverages extensive expertise in biomedical engineering, data analytics, chip design, and mobile and cloud software to create technology that supports decision-making paradigms that achieve better health and economic outcomes. VitalConnect’s products are designed for use in a broad range of inpatient and outpatient settings, such as hospital monitoring, post-discharge care, cardiac monitoring and pharmaceutical solutions.
VitalConnect has an experienced commercial and technical leadership team with a proven track record in the health care market. Additionally, our large portfolio of intellectual properties, including more-than 100 patents, gives VitalConnect a competitive advantage and scalability.
VitalConnect’s innovative technology measures key vital signs including a live ECG, enabling physicians to monitor their patients while they recover at home. VitalConnect’s hospital grade technology …
Posted Hospital at Home Assistive Homecare Devices
Last Updated
It is a platform that is changing the face of healthcare. Vista Solution helps in continuous patient monitoring - anytime, anywhere.
Promote patient mobility in the hospital and home.
Improve …
Posted PCM (Patient Care Management) TeleHealth Chronic Care Management
Last Updated
The launch of the MCT platform puts VitalConnect in a league of its own. When compared to other wearable providers, VitalConnect is in a ‘different category’ with the addition of its mobile cardiac …
Posted Jul 5, 2022 Cardiology Media (Press) Release
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2023 Netspective Media LLC. All Rights Reserved.
Built on Mar 21, 2023 at 8:36am